# Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis

> **NCT00638456** · PHASE2 · COMPLETED · sponsor: **Ranjan Dohil** · enrollment: 32 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Budesonide plus Prevacid
- **DRUG:** placebo plus Prevacid

## Key facts

- **NCT ID:** NCT00638456
- **Lead sponsor:** Ranjan Dohil
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638456, "Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00638456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*